ImmunoGen
IMGN
$31.23
Share price
0.00%
Change (1 day)
622.92%
Change (1 year)
Categories
Operating Margin for ImmunoGen (IMGN)
Operating Margin as of April 2024 (TTM): -203.81%
According to ImmunoGen 's latest financial reports and stock price the company's current Operating Margin is -203.81%. At the end of 2022 the company had an Operating Margin of -203.81%.
Operating Margin history for ImmunoGen from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -203.81% | 2.21% |
| 2021 | -199.41% | 494.57% |
| 2020 | -33.54% | -73.5% |
| 2019 | -126.57% | -59.42% |
| 2018 | -311.94% | 275.08% |
| 2017 | -83.17% | -65.26% |
| 2016 | -239.42% | 237.18% |
| 2015 | -71.01% | -40.4% |
| 2014 | -119.15% | -41.85% |
| 2013 | -204.90% | -54.29% |
| 2012 | -448.24% | 48.49% |
| 2011 | -301.86% | -17.76% |
| 2010 | -367.04% | 220.66% |
| 2009 | -114.47% | 44.01% |
| 2008 | -79.49% | 60.26% |
| 2007 | -49.60% | -10.67% |
| 2006 | -55.53% | 81.58% |
| 2005 | -30.58% | 35.17% |
| 2004 | -22.62% | -91.35% |
| 2003 | -261.49% | 6.08% |
| 2002 | -246.51% | 16.56% |
| 2001 | -211.49% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -111.23% | 🇺🇸 USA |
 Novartis NVS | 17.27% | -108.47% | 🇨🇭 Switzerland |
 Pfizer PFE | 34.61% | -116.98% | 🇺🇸 USA |
 Eli Lilly LLY | 24.66% | -112.10% | 🇺🇸 USA |
 Amgen AMGN | 34.59% | -116.97% | 🇺🇸 USA |
 Sanofi SNY | 18.21% | -108.93% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | 19.24% | -109.44% | 🇺🇸 USA |
 Seagen
SGEN | -30.69% | -84.94% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.